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Few technologies have experienced such
an explosive development and significant
increase in utility as the study, descrip-
tion and manipulation of the genes that
spell out many of the functions of human
life—it almost seems as if the science of
our genes is autopoietic in terms of gen-
erating innovation. Genetic information is
used to address large-scale problems, for
example where whole genome and exome
sequencing advances the understanding of
rare diseases. It is used to tailor individu-
alised health interventions, such as where
the identification of a HER2mutationmay
open the therapeutic pathway to a treat-
ment with Herceptin or where evidence
of a BRCA mutation may trigger poten-
tionally life-saving surgery. From Sir Alec
Jeffrey’s discovery of DNA similarities,
used to identify perpetrators of crime and
family relations in immigration cases, to
direct-to-consumer genetic testing, used
to identify a child’s father (or possi-
bly more frequently—establishing the fact
that the putative father is not the genetic
father) and an individual’s genetic dis-
ease probability (relative to some neb-
ulous population), genetics and -omics
are becoming all-pervasive and, above all,
affordable. The cost of whole genome
sequencing has decreased dramatically
in little more than 10 years—Figure 1
(Wetterstrand, 2013) shows the decreasing
cost of sequencing a genome at NHGRI:
from just under $100m in 2001 to just over
$5000 in 2013. 23 and Me, a prominent
provider of direct-to-consumer genetic
testing for disease probability and ancestry,
started in 2007 at a cost of $999 per
test and now only charges $99 for its
service.1 This is the mainstreaming of
high-impact technologies: similar to the
development and impact of the internet—
once available to the specialised privi-
leged few, with limited features and at
great expense only—the genetic revolu-
tion has taken powerful information out
of the hands of the few and made it avail-
able to many. This increase in density
and availability of meaningful informa-
tion leads to a perceivable public trend
in seeing privacy merely as a symptom of
an informational deficiency, i.e., there is
a plausible argument that the perceived
explosion in information sharing online
may well lead to a desensitization, rather
than an increased fear for privacy. At the
same time, regulatory sciences and the dis-
ciplines looking at ethical, legal, and social
implications of this type of technology
doggedly adhere to their time-honored,
heterogeneous and siloed methodological
traditions: bar some notable exceptions,
lawyers speak to lawyers, ethicists speak to
1http://mediacenter.23andme.com/press-releases/23an
dme-lowers-price-again-ends-subscriptions/.
Accessed 25 May 2013.
FIGURE 1 | DNA sequencing costs: data from the NHGRI genome sequencing program.
ethicists, sociologists speak to sociol-
ogists. Where debate transcends disci-
plinary boundaries, it is often received
with suspicion of the other discipline’s
(or country’s) scholarly conventions, lan-
guage, and style.
This shows, amongst other things, that
we have still not achieved a significant
level of genuine interdisciplinary, transdis-
ciplinary and international collaboration
to address the significant ELSI issues that
have arisen in the past years. So where
does this leave policy and ethics? The creep
of these groundbreaking technologies into
every aspect of modernmedicine and soci-
ety has a profound impact on social cohe-
sion and human self-perception. Issues
of genetic discrimination and stigmati-
sation have been the subject of exten-
sive medico-legal and ethical discussion
for very many years. If vast portions of
our selves are generated using a simple,
now legible, alphabet, what does this mean
for the crude distinctions societies have
made on the basis of phenotype for so
long? Will this lead to a shift from phe-
notype discrimination to genotype dis-
crimination or to the enlightened view
that we are all “made of the same stuff”?
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The speed and significance of the
societal impact of -omics and -etics, for
which we already have the evidence-base,
needs to be matched by coherent and effi-
cient research (infra)structures addressing
ethical, legal and social implications of
these technologies. Moreover, the out-
put of these ELSI activities needs to be
viewed as the engine driving a trans-
lational process—this output needs to
inform policy level decision-making just
as fast as the latest identification of a
biomarker may lead to a bedside benefit.
2012 saw the launch of a global initia-
tive seeking to give the necessary impulse
to create such a structure and a plethora
of endeavours to fill this proposal with
life are under way (Kaye et al., 2012).
The idea is this: the matching scholarly
and policy response to developments
in genetics and genomics is to under-
take high-throughput, massively-open,
global-scale, next-generation ELSI work.
All are welcome.
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